Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Farshchi Zarabi, Sara
  • Chan, Steven
  • Gupta, Vikas
  • Khalif, Dina
  • Lutynski, Andrzej
  • Minden, Mark D
  • Rostom, Amr
  • Rydlewski, Anna
  • Schuh, Andre C
  • Sibai, Hassan
  • Yee, Karen WL
  • Schimmer, Aaron D

publication date

  • January 2, 2018